EVGN
Price:
$2.96
Market Cap:
$14.97M
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develo...[Read more]
Industry
Biotechnology
IPO Date
2010-10-15
Stock Exchange
NASDAQ
Ticker
EVGN
According to Evogene Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.30M. This represents a change of -74.91% compared to the average of 25.11M of the last 4 quarters.
The mean historical Enterprise Value of Evogene Ltd. over the last ten years is 753.42M. The current 6.30M Enterprise Value has changed -16.39% with respect to the historical average. Over the past ten years (40 quarters), EVGN's Enterprise Value was at its highest in in the September 2014 quarter at 3.22B. The Enterprise Value was at its lowest in in the June 2023 quarter at -3941793.20.
Average
753.42M
Median
431.90M
Minimum
11.80M
Maximum
2.30B
Discovering the peaks and valleys of Evogene Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.87%
Maximum Annual Enterprise Value = 2.30B
Minimum Annual Increase = -75.38%
Minimum Annual Enterprise Value = 11.80M
Year | Enterprise Value | Change |
---|---|---|
2023 | 20.16M | 70.87% |
2022 | 11.80M | -67.82% |
2021 | 36.65M | -58.61% |
2020 | 88.56M | -75.38% |
2019 | 359.69M | -28.65% |
2018 | 504.11M | -43.31% |
2017 | 889.25M | -31.30% |
2016 | 1.29B | -36.16% |
2015 | 2.03B | -11.93% |
2014 | 2.30B | -39.12% |
The current Enterprise Value of Evogene Ltd. (EVGN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
22.87M
5-year avg
103.37M
10-year avg
753.42M
Evogene Ltd.’s Enterprise Value is less than Arcus Biosciences, Inc. (1.29B), less than Fate Therapeutics, Inc. (449.69M), less than Surface Oncology, Inc. (59.73M), less than Pluri Inc. (52.10M), less than Lexaria Bioscience Corp. (41.17M), greater than Navidea Biopharmaceuticals, Inc. (-2504975.00), greater than ZyVersa Therapeutics, Inc. (2.58M), greater than Biodexa Pharmaceuticals Plc (-5426545.63), less than Oncorus, Inc. (51.18M), less than Can-Fite BioPharma Ltd. (9.91M), less than ImmuCell Corporation (45.77M), less than Compugen Ltd. (155.00M), less than CollPlant Biotechnologies Ltd. (42.88M), less than Protalix BioTherapeutics, Inc. (0), less than Corvus Pharmaceuticals, Inc. (76.30M), less than Aldeyra Therapeutics, Inc. (237.94M), less than Gamida Cell Ltd. (348.86M), less than Checkpoint Therapeutics, Inc. (57.65M), less than null (88.12M),
Company | Enterprise Value | Market cap |
---|---|---|
1.29B | $1.44B | |
449.69M | $386.05M | |
59.73M | $65.08M | |
52.10M | $29.37M | |
41.17M | $49.49M | |
-2504975.00 | $100.08K | |
2.58M | $2.70M | |
-5426545.63 | $105.64K | |
51.18M | $3.14M | |
9.91M | $14.14M | |
45.77M | $31.25M | |
155.00M | $163.85M | |
42.88M | $58.65M | |
0 | $73.54M | |
76.30M | $252.08M | |
237.94M | $364.25M | |
348.86M | $4.34M | |
57.65M | $93.07M | |
88.12M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evogene Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Evogene Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Evogene Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Evogene Ltd. (EVGN)?
What is the 3-year average Enterprise Value for Evogene Ltd. (EVGN)?
What is the 5-year average Enterprise Value for Evogene Ltd. (EVGN)?
How does the current Enterprise Value for Evogene Ltd. (EVGN) compare to its historical average?